A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy
Clinical trial NCT00738530 · COMPLETED
Trial details
- NCT number
- NCT00738530
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2008-09-01
- Enrollment
- 649
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.